Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Footsie gives up gains

Mon, 11th Jan 2010 16:41

The leading share index gave up early gains to finish only slightly higher as euphoria over strong trade figures from China in December gave way to renewed fears over recovery prospects. China's December imports jumped by 55.9% from the same month the previous year, while exports were 17.7% higher. Continued demand for commodities was behind much of the rise, with crude oil imports climbing 25% and copper imports up by more than a quarter.Oil company Cairn Energy was a strong performer after positive noises from Citigroup. The broker says that fast-tracking the multi-well exploration drilling programme in Greenland has made the group its preferred play on frontier exploration in 2010. Dana is its value play while Tullow could be the most exciting story over the first quarter.Elsewhere in the sector, BP and Shell advanced as oil hit a 15-month high.But miners, which had been among the top risers after the Chinese data came out, gave up these gains in afternoon trading. Silver miner Fresnillo slipped back after it dropped out of the race for Canadian mining company Canplats Resources. Eurasian Natural Resources, Vedanta Resources, Anglo American and Xstrata also closed lower.Bank Barclays has received its third upbeat broker note in less than a week. This time it is Citigroup that reckons the bank is cheap, adding that the market is applying too low a rating to Barclays' earnings. Citigroup's target price is 413p, implying 30% upside.Property groups Land Securities and British Land climbed after the former was added to Goldman Sachs' 'conviction buy' list. Segro, which updated on trading today, rose after Goldman upgraded its rating on the stock to 'neutral'. Inès Reinman, Segro's head of Continental Europe, has resigned from the industrial property group barely a year she was promoted to the board. "Current trading and market conditions are in line with our expectations at the time of our Interim Management Statement issued on 5 November 2009," chief executive Ian Coull added.SABMiller fell after it pulled out of the race to buy the Femsa stable of beer brands leaving the way clear for rival brewer Heineken.Cash strapped plumbers merchant Wolseley is to raise just under £24m from the sale of its Irish businesses. WIBHM, a company backed by private investor, is paying €26.5m for Wolseley Ireland Holdings Limited. The exceptional loss on disposal, excluding currency impacts, is expected to be around €55m (£50m).Online gaming group PartyGaming has tied up an an exclusive, five-year agreement with state-controlled Danske Spil to provide an online gaming platform for poker and casino games in Denmark. Outdoor clothing retailer Blacks Leisure said it is mulling a possible equity fundraising in the first quarter to raise between £15m and £20m depending on investor demand. It hopes to roll out new stores, having closed 87 loss-making outlets in the fourth quarter of 2009. It said trading in the ongoing stores was very healthy with like-for-like sales increasing by 12.0% in the half year ended 7 JanuaryThe US Navy has awarded defence and aerospace group Cobham a contract worth up to $11.5m for the UK group. Cobham has won the Band 5/6 TWT (Travelling-wave Tube) Replacement Module Assembly (TRMA) development contract.Stem cell therapy group ReNeuron said it is on track to start human trials of its flagship treatment ReN001 for disabled stroke patients in the first quarter of this year.EMED Mining's quest to reopen the Rio Tinto mine in Spain moved a step closer following recent court rulings deemed favourable to the company. The cases all related to objections by previous stakeholders in the mine.FTSE 100 - RisersLand Securities Group (LAND) 683.00p +2.86%TUI Travel (TT.) 271.00p +2.69%British Land Co (BLND) 473.40p +2.60%BG Group (BG.) 1,223.00p +2.43%Marks & Spencer Group (MKS) 375.00p +2.35%Cairn Energy (CNE) 370.30p +2.32%Kingfisher (KGF) 230.80p +2.30%BP (BP.) 635.50p +2.22%SEGRO (SGRO) 350.70p +1.95%Morrison (Wm) Supermarkets (MRW) 290.20p +1.90%FTSE 100 - FallersEurasian Natural Resources (ENRC) 1,010.00p -2.32%Standard Chartered (STAN) 1,590.00p -2.09%Legal & General Group (LGEN) 82.55p -2.08%SABMiller (SAB) 1,801.00p -2.01%Prudential (PRU) 626.50p -1.88%Man Group (EMG) 314.00p -1.81%Vedanta Resources (VED) 2,834.00p -1.80%Anglo American (AAL) 2,845.00p -1.79%Xstrata (XTA) 1,224.50p -1.76%Fresnillo (FRES) 852.00p -1.62%FTSE 250 - RisersRenishaw (RSW) 602.00p +5.61%St James's Place (STJ) 270.00p +5.47%Electra Private Equity (ELTA) 1,280.00p +5.09%Interserve (IRV) 229.90p +5.07%Lamprell (LAM) 211.00p +4.87%BlueBay Asset Management (BBAY) 347.40p +4.48%Halfords Group (HFD) 436.00p +4.31%Dechra Pharmaceuticals (DPH) 493.00p +4.23%Telecity Group (TCY) 424.00p +3.95%Domino Printing (DNO) 353.60p +3.66%FTSE 250 - FallersImagination Technologies (IMG) 262.80p -5.81%Weir Group (WEIR) 798.00p -4.09%Carphone Warehouse Group (CPW) 192.20p -2.88%Close Brothers Group (CBG) 712.00p -2.40%Unite Group (UTG) 289.10p -2.36%Barratt Developments (BDEV) 138.70p -2.26%Charter International (CHTR) 770.00p -2.10%SIG (SHI) 122.80p -1.92%DS Smith (SMDS) 125.70p -1.80%Investec (INVP) 454.80p -1.69%
More News
12 Sep 2018 14:44

ReNeuron pleased with progress on several therapy fronts

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on its trading on Wednesday, as investors gathered for the firm's annual general meeting, announcing that following recent co-ordinating ethics committee approval, the first clinical site has now been initiated in the US Phase IIb study with its CTX cell therapy candidate for stroke disability.

Read more
12 Sep 2018 13:54

ReNeuron Expects To Enroll First Patient For Stroke Study Shortly

LONDON (Alliance News) - ReNeuron Group PLC said Wednesday it expects to enroll the first patient in its stroke disability study "shortly".The company said that the first clinical

Read more
5 Jul 2018 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 6 July SVM UK Emerging FundFull Year Results Monday 9 July GroupHalf

Read more
19 Apr 2018 13:17

ReNeuron Wins GBP1.5 Million Grant For Stem Cell Therapy Development

LONDON (Alliance News) - ReNeuron Group PLC on Thursday said it is the "lead" industry participant in a new GBP1.5 million grant from the UK's innovation agency Innovate grant has to

Read more
3 Apr 2018 13:29

Portugal looks to renewables as March output tops mainland power demand

LISBON, April 3 (Reuters) - For the first time in at least four decades, Portugal's monthly renewable energy production in March exceeded power demand

Read more
26 Mar 2018 15:53

ReNeuron Now Expects hRPC Stem Cell Trial Data In First Half Of 2019

LONDON (Alliance News) - ReNeuron Group PLC on Monday said it has decided to adjust the number of clinical sites for its CTX stem cell therapy candidate study, and now expects

Read more
5 Dec 2016 11:06

ReNeuron's first half revenues supported by new drug developments

(ShareCast News) - ReNeuron, an AIM-listed UK based developer of cell-based therapeutics, saw first half revenues double due to a series of successful drug trials. Revenues were £22,000 for the six months ended 30 September 2016 up from £11,000 in the first half of 2015. During the period, the grou

Read more
4 Dec 2016 14:45

Sunday share tips: ReNeuron, Clipper Logistics, RM Secured Direct Lending

(ShareCast News) - Shares of ReNeuron are for brave investors only, said the Sunday Times' Inside the City column. The stem cell pioneer is scheduled to publish the results of second-phase clinical trials of its potential stroke paralysis treatment alongside its interim results on Monday. ReNeuron's

Read more
6 Sep 2016 11:38

ReNeuron reports positive progress in clinical trials

(ShareCast News) - UK-based developer of cell-based therapeutics ReNeuron Group provided a trading update ahead of its annual general meeting on Tuesday. The AIM-traded firm reported that all patients have been treated in the PISCES II Phase II clinical trial of its CTX cell therapy candidate for pa

Read more
7 Jul 2016 09:37

ReNeuron Annual Loss Widens As Product Trials Ramp Up

Read more
4 Jul 2016 15:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
13 Jun 2016 07:58

ReNeuron Completes Phase II Stroke Therapy Trial Patient Recruitment

Read more
9 Jun 2016 08:55

ReNeuron Selects Glioblastoma Multiforme As First Clinical Target

Read more
8 Jun 2016 08:36

ReNeuron Progressing Blindness Candidate Through Phase I/II Trial

Read more
15 Mar 2016 09:52

ReNeuron Says First Patient Treated For Retinitis Pigmentosa

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.